GADD34 facilitates cell death resulting from proteasome inhibition

Anticancer Research

Volumn 35, Issue 10, 2015, Pages 5317-5324

  Liu, Lintao ^a   Ito, Sachiko ^a   Nishio, Naomi ^a   Sun, Yang ^a   Chen, Nana ^a   Tanaka, Yuriko ^a   Isobe, Ken Ichi ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Autophagy; Cell death; EIF2 ; GADD34; Proteasome inhibition

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; INITIATION FACTOR 2ALPHA; PROTEASOME; REACTIVE OXYGEN METABOLITE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; INITIATION FACTOR 2; LEUPEPTIN; PHOSPHOPROTEIN PHOSPHATASE 1; PPP1R15A PROTEIN, MOUSE;

ARTICLE; AUTOPHAGY; CELL DEATH; ENZYME INHIBITION; GADD34 GENE; GENE; GENE EXPRESSION; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; STAINING; WESTERN BLOTTING; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENDOPLASMIC RETICULUM STRESS; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; MOUSE;

ANIMALS; AUTOPHAGY; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; EMBRYO, MAMMALIAN; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; LEUPEPTINS; MICE; PROTEIN PHOSPHATASE 1; REACTIVE OXYGEN SPECIES;

EID: 84942741780     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Suraweera A, Munch C, Hanssum A, and Bertolotti A: Failure of amino acid homeostasis causes cell death following proteasome inhibition. Molecular cell 48: 242-253, 2012.
2. Schwartz AL and Ciechanover A: Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annual review of pharmacology and toxicology 49: 73-96, 2009.
3. Jiang HY and Wek RC: Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J Biol Chem 280: 14189-14202, 2005.
4. Park HS, Jun do Y, Han CR, Woo HJ and Kim YH: Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells. Biochem Pharmacol 82: 1110-1125, 2011.
5. Maharjan S, Oku M, Tsuda M, Hoseki J and Sakai Y: Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Scientific reports 4: 5896, 2014.
6. Ling YH, Liebes L, Zou Y and Perez-Soler R: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J Biol Chem 278: 33714-33723, 2003.
7. Perez-Galan P, Roue G, Villamor N, Montserrat E, Campo E and Colomer D: The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 107: 257-264, 2006.
8. Maiuri MC, Zalckvar E, Kimchi A and Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Bio 8: 741-752, 2007.
9. Iwata A, Riley BE, Johnston JA and Kopito RR: HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem 280: 40282-40292, 2005.
10. Rideout HJ, Lang-Rollin I and Stefanis L: Involvement of macroautophagy in the dissolution of neuronal inclusions. The international journal of biochemistry & cell biology 36: 2551-2562, 2004.
11. Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nature reviews Cancer 5: 726-734, 2005.
12. Levine B and Yuan J: Autophagy in cell death: an innocent convict? The Journal of clinical investigation 115: 2679-2688, 2005.
13. Nawrocki ST, Carew JS, Dunner K Jr., Boise LH, Chiao PJ, Huang P, Abbruzzese JL and McConkey DJ: Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer research 65: 11510-11519, 2005.
14. Brush MH and Shenolikar S: Control of cellular GADD34 levels by the 26S proteasome. Mol Cell Biol 28: 6989-7000, 2008.
15. Kojima E, Takeuchi A, Haneda M, Yagi F, Hasegawa T, Yamaki K, Takeda K, Akira S, Shimokata K and Isobe K: The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress-elucidation by GADD34-deficient mice. Faseb Journal 17: 1573, 2003.
16. Ito S, Tanaka Y, Oshino R, Aiba K, Thanasegaran S, Nishio N and Isobe KI: GADD34 inhibits activation-induced apoptosis of macrophages through enhancement of autophagy. Scientific reports 52015.
17. Novoa I, Zeng H, Harding H and Ron D: Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 153: 1011-1022, 2001.
18. Uddin MN, Ito S, Nishio N, Suganya T and Isobe K: Gadd34 induces autophagy through the suppression of the mTOR pathway during starvation. Biochemical and Biophysical Research Communications 407: 692-698, 2011.
19. Ma XM and Blenis J: Molecular mechanisms of mTORmediated translational control. Nat Rev Mol Cell Biol 10: 307-318, 2009.
20. He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annual review of genetics 43: 67-93, 2009.
21. Klionsky DJ: Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544, 2012.
22. Adams J: The development of proteasome inhibitors as anticancer drugs. Cancer cell 5: 417-421, 2004.
23. Voorhees PM, Dees EC, O'Neil B, and Orlowski RZ: The proteasome as a target for cancer therapy. Clinical cancer research: an official journal of the American Association for Cancer Research 9: 6316-6325, 2003.
24. Yuan BZ, Chapman J, and Reynolds SH: Proteasome inhibitors induce apoptosis in human lung cancer cells through a positive feedback mechanism and the subsequent Mcl-1 protein cleavage. Oncogene 28: 3775-3786, 2009.
25. Scagliotti G: Proteasome inhibitors in lung cancer. Critical reviews in oncology/hematology 58: 177-189, 2006.
26. Bunn PA Jr.: The potential role of proteasome inhibitors in the treatment of lung cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 10: 4263s-4265s, 2004.